Search research articles
Contact Us
Filters
Showing results (141-150 of 512) with videos related to
Page
of 52
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
May 31, 2016
Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network
Jordi Remon, Nicolas Girard, Julien Mazieres, et al.
Future Oncology (London, England)
|
February 17, 2025
REZILIENT3: randomized phase III study of first-line zipalertinib plus chemotherapy in patients with <i>EGFR</i> exon 20 insertion-mutated NSCLC
John V Heymach, Helena A Yu, Benjamin Besse, et al.
JCO Precision Oncology
|
August 1, 2024
Disease Course and Treatment Outcomes in Patients With De Novo Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Insertion: Two Case Reports
Lodovica Zullo, Elora Castanet, Zineb Maaradji, et al.
Virchows Archiv : an International Journal of Pathology
|
January 16, 2013
Thymic carcinomas: clinicopathologic study of 37 cases from a single institution
Vincent Thomas de Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 1, 2011
Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting
Cesare Gridelli, Rolf Stahel, Benjamin Besse, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 11, 2016
Erratum to "Sunitinib in patients with advanced thymic malignancies: cohort from the French RYTHMIC network" [Lung Cancer, 97 (July 2016), 99-104]
Jordi Remon, Nicolas Girard, Julien Mazieres, et al.
Molecular Oncology
|
April 10, 2012
The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: the case of the Institut Gustave Roussy
Monica Arnedos, Fabrice André, Françoise Farace, et al.
Bulletin Du Cancer
|
April 23, 2021
[Impact of the use of systemic corticosteroid therapy on the effectiveness of immune checkpoint inhibitors]
Reda El Hazzaz, Maria Kfoury, Pernelle Lavaud, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 24, 2023
Biomarkers of response to immunotherapy in early stage non-small cell lung cancer
Matthieu Roulleaux Dugage, Víctor Albarrán-Artahona, Juan Carlos Laguna, et al.
Journal for Immunotherapy of Cancer
|
June 14, 2020
IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment
Mélanie Desbois, Coralie Béal, Mélinda Charrier, et al.
Page
of 52
Search research articles
Search
Showing results (141-150 of 512) with videos related to
Sort By:
Page
of 52
Lung Cancer (Amsterdam, Netherlands)
|
May 31, 2016
Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network
Jordi Remon, Nicolas Girard, Julien Mazieres, et al.
Future Oncology (London, England)
|
February 17, 2025
REZILIENT3: randomized phase III study of first-line zipalertinib plus chemotherapy in patients with <i>EGFR</i> exon 20 insertion-mutated NSCLC
John V Heymach, Helena A Yu, Benjamin Besse, et al.
JCO Precision Oncology
|
August 1, 2024
Disease Course and Treatment Outcomes in Patients With De Novo Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Insertion: Two Case Reports
Lodovica Zullo, Elora Castanet, Zineb Maaradji, et al.
Virchows Archiv : an International Journal of Pathology
|
January 16, 2013
Thymic carcinomas: clinicopathologic study of 37 cases from a single institution
Vincent Thomas de Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 1, 2011
Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting
Cesare Gridelli, Rolf Stahel, Benjamin Besse, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 11, 2016
Erratum to "Sunitinib in patients with advanced thymic malignancies: cohort from the French RYTHMIC network" [Lung Cancer, 97 (July 2016), 99-104]
Jordi Remon, Nicolas Girard, Julien Mazieres, et al.
Molecular Oncology
|
April 10, 2012
The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: the case of the Institut Gustave Roussy
Monica Arnedos, Fabrice André, Françoise Farace, et al.
Bulletin Du Cancer
|
April 23, 2021
[Impact of the use of systemic corticosteroid therapy on the effectiveness of immune checkpoint inhibitors]
Reda El Hazzaz, Maria Kfoury, Pernelle Lavaud, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 24, 2023
Biomarkers of response to immunotherapy in early stage non-small cell lung cancer
Matthieu Roulleaux Dugage, Víctor Albarrán-Artahona, Juan Carlos Laguna, et al.
Journal for Immunotherapy of Cancer
|
June 14, 2020
IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment
Mélanie Desbois, Coralie Béal, Mélinda Charrier, et al.
Page
of 52